Bonesupport Holding AB (publ) (0RQO.L) Comparison with companies in other sectors?

Bonesupport Holding AB (publ) has a share price of 65.86M. You can analyze Bonesupport Holding AB (publ) (0RQO.L) competitors across different market sectors through stock heatmaps.

What are 0RQO.L's NET and operating margins?

Bonesupport Holding AB (publ) (0RQO.L) operating margin is around 0.16, and net profit margin is approximately 0.12 as of the latest reports.

In what way does 0RQO.L's earnings per share (EPS) trend reflect its financial momentum?

Bonesupport Holding AB (publ) (0RQO.L) EPS is -1.27 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Bonesupport Holding AB (publ) is -245.53, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Bonesupport Holding AB (publ)?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Bonesupport Holding AB (publ) like P/E which is 168.72, P/B which is 27.86, and PEG which is -20.15. Compare them with sector averages to evaluate if the stock is priced fairly.

Bonesupport Holding AB (publ)

0RQO.L•LSE

Healthcare

Medical - Pharmaceuticals

£315.89

£-9.69(-2.98%)

Fundamental Analysis of Bonesupport Holding AB (publ) (0RQO.L)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-1.27

P/E Ratio

-245.53

ROE

0.18%

Net Margin

0.12%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$20.60B

Shares OutstandingTotal number of shares issued

$65.86M

Book Value/ShareNet worth per share

$11.25

Revenue/ShareAnnual revenue per share

$15.15

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-1.274

Net MarginNet income as percentage of revenue

12.26%

Operating MarginOperating income as percentage of revenue

16.49%

ROEReturn on shareholders' equity

17.73%

ROAReturn on total assets

13.65%

ROCEReturn on capital employed

22.02%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$1.38

Cash/ShareCash and equivalents per share

$4.06

FCF YieldFree cash flow as percentage of market cap

0.44%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for 0RQO.LFinancial Ratios Analysis details for 0RQO.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 0RQO.LSector Benchmarking details for 0RQO.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Bonesupport Holding AB (publ) Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Bonesupport Holding AB (publ). Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Bonesupport Holding AB (publ)'s unique business strengths and challenges.

Key Financial Metrics for Bonesupport Holding AB (publ)

For Bonesupport Holding AB (publ), essential financial indicators include EPS -1.27, PE -245.53, and ROE 0.18. These key ratios reveal insights into Bonesupport Holding AB (publ)'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Bonesupport Holding AB (publ) with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Bonesupport Holding AB (publ)

Metrics like Net Margin 12.26% and ROA 13.65% shed light on how well Bonesupport Holding AB (publ) is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Bonesupport Holding AB (publ) can sustain its operations and continue growing in the future.

Valuation and Market Position of Bonesupport Holding AB (publ)

Using ratios such as P/B Ratio 27.86 and PEG Ratio -20.15, investors can assess whether Bonesupport Holding AB (publ) is appropriately valued based on its financials and growth potential. These figures, combined with Bonesupport Holding AB (publ)'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Bonesupport Holding AB (publ)

Financial health indicators, such as Debt/Equity Ratio 0.02 and Cash Flow $1.38, provide a snapshot of Bonesupport Holding AB (publ)'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Bonesupport Holding AB (publ), is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Bonesupport Holding AB (publ)

Investing in Bonesupport Holding AB (publ) based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Bonesupport Holding AB (publ) focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;